Le Lézard
Classified in: Environment, Health

GBLT Receives Shareholder Approval for Delisting from TSX Venture Exchange


TORONTO and DUREN, Germany, April 26, 2024 /CNW/ - GBLT Corp. (TSXV: GBLT) ("GBLT" or the "Company") announces that minority shareholders have approved the voluntary delisting (the "Delisting") of the common shares of the Company from the TSX Venture Exchange ("TSXV").  Approval for the delisting was received at the annual general and special meeting (the "Meeting") of shareholders held on April 26, 2024.  Subject to final approval of the TSXV, the delisting is expected to take effect at the close of markets on or about May 13, 2024.

For further information regarding the Delisting, readers are encouraged to review the Company's management information circular (the "Circular") prepared in connection with the Meeting.  The Circular is available under the SEDAR+ profile for GBLT at www.sedarplus.ca.

The Company also announces that Kyle Appleby has resigned as Chief Financial Officer effective immediately, and is replaced by Sven Carbow, the Company's Chief Operating Officer.

About GBLT:

GBLT Corp., through its operating company, GBT GmbH, designs, manufactures and supplies mobile storage, and battery solutions. GBLT is also a leading provider of renewable energy solutions via its solar division, participating in the rapidly growing solar energy market. In addition, the Company offers consumer healthcare and wellness products to some of the largest retail chains across the globe. GBT is also an official licensee for AGFAPHOTO mobile energy products. The Company's branded healthcare and wellbeing products are primarily sold throughout Europe under Dr. Senst brand.

For more information, please visit www.gbt-international.com and www.gbltcorp.com. 

Forward-Looking Information

Certain statements in this news release, constitute "forward looking statements" within the meaning of that phrase under applicable Canadian securities law, including, but not limited to statements regarding the Delisting. These statements reflect management's current assumptions and expectations and by their nature are subject to certain underlying assumptions, known and unknown risks and uncertainties and other factors which may cause actual results, performance or events to be materially different from those expressed or implied by such forward looking statements. There is no guarantee that the Company will continue with the Delisting or receive the necessary shareholder and regulatory approvals to proceed with the Delisting. Except as required pursuant to applicable securities laws, the Company will not update these forward-looking statements to reflect events or circumstances after the date hereof. Readers are cautioned not to place undue reliance on forward looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE GBLT Corp.


These press releases may also interest you

at 12:25
US Medical Innovations, LLC (USMI) announced today it has received FDA 510k Clearance (K240297) for the Canady Helios Cold Plasmatm (CHCP) Ablation System for the ablation of soft tissue during surgery. The CHCP system consists of the Canady Helios...

at 12:18
DRI Healthcare Trust ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 7, 2024. All of the nominees for election as trustees of the Trust referred to in its management...

at 12:15
Modern Vision Centers (MVC), a revolutionary network of premier optometry, medical ophthalmology, and refractive surgery practices, proudly announces its official debut, offering comprehensive and personalized eye care solutions that set a new...

at 12:10
The rising pediatric mental health crisis has put a strain on emergency departments across the country. "The Development and Implementation of a Pediatric Nursing Emergency Behavioral Health Assessment Tool" in the May issue of the Journal of...

at 12:05
Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system...

at 12:05
LGI Healthcare Solutions, a Canadian leader in healthcare IT, proudly announces the selection of its LGI Education (MedSIS 3C)...



News published on and distributed by: